Searched for
GENE BASED THERAPIES
India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
Tata-backed MedTherapy claims CAR-T breakthrough with one-day productionTata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can redu...
Experimental pancreatic cancer drug appears to dramatically improve one year survival ratesA groundbreaking study published in Nature Medicine reveals that the experimental drug Elraglusib, when combined with standard chemotherapy...
India should chart own path in treatment of rare diseases: ICMR chiefIndia is taking a groundbreaking step forward in the realm of rare disease care with a distinctive approach that champions local ingenuity ...
Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
Trump tariffs hit patented drugs: Jefferies, Nomura explain impact on pharma stocksThe US has slapped up to 100% tariffs on patented drugs, sparing generics and biosimilars but exposing India’s speciality pharma players. S...
US FDA approves Novartis' gene therapy for rare muscle disorderThe US FDA has approved Novartis' new gene therapy, Itvisma, which is for patients aged two and above with spinal muscular atrophy. Itvisma...
Biotech startup Helex raises $3.5 million in round led by pi VenturesBluehill Capital, SOSV, and other global investors participated in the round. The Hyderabad- and US-based biotech startup will use the fund...
Bharat Biotech invests Rs 600 cr to expand into cell, gene therapiesAs per Bharat Biotech, the facility will tackle scientific challenges such as targeted gene expression, immune system modulation, and long-...
US FDA approves two gene therapies for sickle cell diseaseThe US Food and Drug Administration (FDA) has approved two gene therapies for sickle cell disease, including the first treatment in the US ...
Cellogen to bring next-gen cancer therapy to India"Chimeric Antigen Receptor cells represent a cutting-edge technology that holds great promise for cancer treatment. We are delighted to off...
How common cold viruses are being used in vaccines from Russia, ChinaSome researchers believe the strong immune response that caused problems with gene therapy makes these vectors well suited to vaccines, whe...
- Researchers edit gene to reduce blood cholesterol levels
New York, April 28 (IANS) Using the cutting-edge CRISPR/Cas9 genetic engineering technique, researchers, including one of Indian-origin, ha...
Scientists identify gene behind triple-negative breast cancerThe study opens the door for therapies which suppress the gene and for screening that would pick up the risk early.
Cause of malaria drug resistance in Southeast Asia identifiedGrowing resistance to malaria drugs in Southeast Asia is caused by a single mutated gene inside the disease-causing parasite, according to ...
Indian-origin doctor performs life-saving heart surgery on US actor Ernie LivelyDr Patel uses a minimally invasive technique where he goes backwards through a patient's main cardiac vein, or coronary sinus, and inserts ...
Sun Pharma gains on JV to develop new drugsThe joint venture will leverage Sun Pharma’s global capabilities and experience in developing and manufacturing complex dosage forms and sp...
Sun Pharma inks JV with US-based Intrexon Corp to develop gene therapiesThe 50:50 deal will leverage Sun Pharma’s global capabilities and experience in developing complex dosage forms and specialty pharmaceutica...
- European Commission set to approve first drug based on gene therapy
The idea was conceived in the 1970s but after that, a large number of clinical trials did not result in a commercial drug.